Healthcare >> CEO Interviews >> February 19, 2001
JAMES R. WEBSTER is President of Drug Royalty Corporation Inc., a
company that is a leader in the global healthcare royalty business by
providing unique financial solutions to health-related organizations.
Mr. Webster was formerly Vice President of Indal Limited, a diversified
public company, prior to which he was Executive Vice President of one of
Indal's business units. Earlier he was Vice President, Corporate
Development of Indal Limited, where he was involved in mergers,
acquisitions, and joint venture negotiations. In addition to his
responsibilities at Drug Royalty, Mr. Webster is a member of the Board
of Phytogen Life Sciences Inc. Mr. Webster is a Chartered Accountant,
and has an MBA from the University of Western Ontario and a B Comm from
the University of Toronto. He attended the Advanced Executive Management
program at Columbia University. Mr. Webster published two articles on
royalty-based financing in Canadian Treasurer, the first in
February/March 1996 entitled 'A Win/Win Solution to Strategic
Financing,' and the second in August/September 1999 entitled 'Extracting
a Technology's Value Through Royalties.' He is past-President of the
Rotary Club of Mississauga-West. Profile
company?
Mr. Webster: Drug Royalty acquires and creates royalties in the
pharmaceutical and biotech sector. We look for
